Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia
ConclusionFerritin is deregulated in most AML patients likely through inflammation, associated with chemoresistance, and could represent a new therapeutic target.
Source: European Journal of Haematology - Category: Hematology Authors: Sarah Bertoli,
Etienne Paubelle,
Emilie B érard,
Estelle Saland,
Xavier Thomas,
Suzanne Tavitian,
Marie‐Virginie Larcher,
François Vergez,
Eric Delabesse,
Audrey Sarry,
Françoise Huguet,
Clément Larrue,
Claudie Bosc,
Thomas Farge,
Jean Tags: ORIGINAL ARTICLE Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Chemotherapy | Databases & Libraries | Dexamethasone | Genetics | Hematology | Iron | Leukemia | Men | Stem Cell Therapy | Stem Cells | Study